61 |
Long-term clinical outcome of treatment for chronic hepatitis CVeldt, Bartholomeus Johannes, January 2008 (has links)
Thesis Erasmus University Rotterdam. / ook verschenen in gedrukte versie. With bibliogr., with a summary in Dutch.
|
62 |
Identifizierung von Proteom Pattern und Proteinmarkern durch SELDI-TOF MS bei Patienten mit chronischer Hepatitis CGöbel, Thomas January 2008 (has links)
Zugl.: Düsseldorf, Univ., Diss., 2008
|
63 |
Evaluation and comparison of genotyping assays for molecular epidemiological study of HCV in Hong KongCheng, Pui-sai., 鄭佩茜. January 2007 (has links)
published_or_final_version / Medical Sciences / Master / Master of Medical Sciences
|
64 |
Molecular evolution of hepatitis C virus quasispecies.Oon, Aileen, Biotechnology & Biomolecular Sciences, Faculty of Science, UNSW January 2007 (has links)
The viral dynamics of the hepatitis C virus (HCV) in newly acquired infection are not well understood. HCV exists within an individual as a spectrum of minor variants termed quasispecies. The evolution of minor variants may contribute to viral escape of the host?s immune response, thereby facilitating development of chronic infection. The hypervariable 1 region (HVR1) is the most heterogeneous part of the HCV genome and contains a putative B-cell epitope. Thus, diversity in HVR1 could be a strategy used to evade neutralising antibodies. Acutely infected individuals (n=24) were examined with the aim of defining HVR1 quasispecies diversity in acute infection. The characterisation of the E1/HVR1 sequence and host specific evolution of HCV minor variants in treatment nonresponders was also investigated. HCV E1/HVR1 fragments were amplified from 48 sera using a combined reverse transcription-polymerase chain reaction (RT-PCR). Products were TA cloned into pCRIITOPO and approximately 10-20 clones were sequenced from each sample. HVR1 quasispecies diversity was examined longitudinally via sequence analysis. Quasispecies diversity was characterised primarily by mean nucleotide diversity. The mean HVR1 diversity of the acute cohort (n=48; 2.12% ?? 2.22) was lower than the diversity obtained for a cohort of chronically infected individuals (n=99; 4.5% ?? 5.1). There was no significant difference in mean HVR1 diversity between the HIV/HCV co-infected and HCV mono-infected groups (p=0.99) or between the clearer and non-clearer groups (p=0.85). Examination of amino acid usage and the hydropathic profile of each position in HVR1 revealed that sequence variation was confined to specific sites. The investigation of host specific evolution of HVR1 quasispecies demonstrated that minor variants (comprising 10- 20% of a population) became the dominant species over time in two treatment non-responders. These variants bore mutations that were not reflected in the consensus sequence of their respective populations at the initial timepoint analysed. Common infection was identified by 98% HVR1 sequence homology within two pairs of individuals. The evolution of common strains appeared to be different between individuals, suggesting host pressures may influence quasispecies evolution. This thesis provided an insight into the viral dynamics and host specific evolution of acute phase quasispecies.
|
65 |
Hepatitis B and hepatitis C virus in an antenatal population : an epidemiological studyPolis, Suzanne, Public Health & Community Medicine, Faculty of Medicine, UNSW January 2005 (has links)
Although Australian epidemiology of HBV and HCV has been well described for populations groups at higher risk, but the information available for groups generally considered to be lower risk is much more limited. An understanding of the prevalence of these infections and their risk factors in antenatal women is important to guide testing policy and practice. A study was therefore conducted of the epidemiology of hepatitis B and hepatitis C infection in women. In addition, women were asked about their experience with antenatal testing. A total of 516 women participated in the survey, of these 479 (95%) women had been tested for HCV antibodies .The prevalence of HCV antibodies was 4% overall, and 2% among women who were unaware of their HCV status prior to their antenatal test. A history of injecting drug use and residing with a HCV positive person were significantly associated with HCV infection in multivariate analyses. HBV testing was conducted in 468 (99.6%) of women, and the overall prevalence was 2%. Risk factors identified were birthplace in countries of South East Asia. Women were asked about their perception of antenatal testing and pre-test information. Nearly a third (143, 30.5%) of women who had been tested for HCV infection either said that they did not know whether they had been tested, or said that they had declined testing. The corresponding proportion for HBV infection was 28.8% (135). Over 65% and 66% of women said that had not received any information about testing for HCV and HBV respectively. The finding that virtually all antenatal women were being tested for HCV was in contrast to government and non-government organisation policies of ???selective??? screening in place during the study period. Of concern was the substantial proportion of women who were tested despite reporting that they had declined their clinician???s offer to test for HCV and HBV, and the large number of women who reported an absence of pre-test information. Women who said they had received information reported the delivery and quality of information varied according to the antenatal clinician group, but perceived the overall quality as poor.
|
66 |
Hepatitis C testing among young people who experience homelessness in MelbourneMyers, Paul Michael Unknown Date (has links) (PDF)
Despite the large number of hepatitis C tests performed in Australia each year and the effort expended on developing and implementing policies to regulate this practice, very little research has been undertaken on the human factors associated with hepatitis C testing. This thesis aims to: 1) examine patterns (prevalence and incidence) of hepatitis C testing among young people who experience homelessness in Melbourne, Australia, and how they relate to behavioural and contextual factors, and 2) examine the contexts in which hepatitis C testing occurs for these young people. Two studies were undertaken to address these aims. The first employed longitudinal panel surveys collected from young people who had recently become homeless for the first time (N=165) over three waves: baseline, 12-month and 24-months. The second employed semi-structured qualitative interviews 24-months after baseline with 20 young people recruited from the longitudinal cohort.
|
67 |
Living with Hepatitis CHopwood, Maxwell Norman. January 2007 (has links)
Proefschrift Maastricht. / Lit. opg. - Met samenvatting in het Nederlands.
|
68 |
Evaluation and comparison of genotyping assays for molecular epidemiological study of HCV in Hong Kong /Cheng, Pui-sai. January 2007 (has links)
Thesis (M. Med. Sc.)--University of Hong Kong, 2007.
|
69 |
Modelling human immunodeficiency virus and hepatitis C virus epidemics in Australia /Gao, Zhanhai. January 2001 (has links)
Thesis (Ph. D.)--University of New South Wales, 2001. / Also available online.
|
70 |
Hepatitis B and hepatitis C virus in an antenatal population : an epidemiological study /Polis, Suzanne. January 2005 (has links)
Thesis (M.P.H.)--University of New South Wales, 2005. / Also available online.
|
Page generated in 0.0615 seconds